Semaglutid na Tirzepatid imaze kumenyekana byihuse kubera kugabanya ibiro no gucunga diyabete. Byombi biri mubyiciro bya incretin bigana ariko bikora muburyo butandukanye. Gusobanukirwa itandukaniro ryabo nibyingenzi kubayobora umubyibuho ukabije cyangwa diyabete yo mu bwoko bwa 2.
Muri iki kiganiro, tuzasesengura uburyo, imikorere, ingaruka, nuburyo bwo guhitamo imiti ikwiye. Buri gihe ujye ubaza abashinzwe ubuzima kugirango bakuyobore.
Semaglutid ikora nka GLP-1 (glucagon isa na peptide-1) reseptor agonist, yigana imisemburo karemano umubiri wawe ukora. Iyi misemburo igira uruhare runini mugutunganya ubushake bwo kurya, urugero rwisukari mu maraso, no gusiba gastric. Iyo itanzwe, Semaglutid iteza imbere ibyiyumvo byuzuye, igabanya umuvuduko wa gastrica, igabanya ubushake bwo kurya, kandi ifasha umubiri kugenzura umusaruro wa glucose. Ibi bituma bigira akamaro mu gucunga diyabete yo mu bwoko bwa 2 no gushyigikira kugabanya ibiro.
Semaglutid yemerewe na FDA kuvura diyabete yo mu bwoko bwa 2 ku mazina ya Ozempic na Rybelsus, no kugabanya ibiro ku izina rya Wegovy. Ifite kandi akamaro ku barwayi bafite indwara z'umutima n'imitsi, kuko byagaragaye ko igabanya ibyago byo kwandura indwara zikomeye z'umutima n'imitsi nk'indwara z'umutima ndetse na stroke ku bantu barwaye diyabete. Usibye uruhare rwayo mu kurwanya diyabete, Semaglutid ifasha kugabanya ingaruka ziterwa n'indwara z'umutima, cyane cyane ku bantu bafite umubyibuho ukabije.
Semaglutid yerekanye ko ifite akamaro kanini mu gufasha kugabanya ibiro. Ubushakashatsi bw’ubuvuzi bwerekanye ko, ugereranije, abarwayi bafata Semaglutid batakaza hafi 17% by’ibiro by’umubiri nyuma y’ibyumweru 68 bivuwe. Ibi biri hejuru cyane ugereranije no kuvura umwanya, aho kugabanya ibiro ari bike. Semaglutid igira akamaro cyane iyo ihujwe nimirire myiza hamwe na gahunda yimyitozo ngororamubiri, byerekana akamaro ko guhindura imibereho hamwe nubuvuzi.
Tirzepatid ikora itandukanye na Semaglutid ikora kuri reseptor zombi za GLP-1 na GIP (glucose-biterwa na insulineotropique polypeptide). Iki gikorwa cya reseptor ebyiri cyongera isukari mu maraso kandi kigatera kugabanya ibiro. GIP, kimwe na GLP-1, igira uruhare mu gusohora insuline, kugaburira ibyifuzo, no kuringaniza ingufu. Ubushobozi bwa Tirzepatid bwo gukora reseptors zombi butanga uburyo bwuzuye bwo kurwanya diyabete n'umubyibuho ukabije.
Tirzepatid, igurishwa ku mazina ya Mounjaro (kuri diyabete) na Zepbound (kubera kugabanya ibiro), yemerewe na FDA gucunga diyabete yo mu bwoko bwa 2 n'umubyibuho ukabije. Vuba aha, Tirzepatid yemerewe kandi kuvura ibitotsi bitagereranywa kandi bikabije bikabije (OSA) ku barwayi bafite umubyibuho ukabije, bitanga porogaramu nini zirenze gucunga ibiro no kugenzura glucose.
Mu bigeragezo bivura, Tirzepatid yerekanye ibiro byinshi ugereranije na Semaglutid. Abarwayi bafata Tirzepatid bagize ikibazo cyo kugabanuka kugera kuri 21%, bitewe na dosiye nigihe cyo kuvura. Iki nigisubizo gishimishije, cyane cyane ugereranije na Semaglutid kugabanya 17%. Ibikorwa bibiri bya Tirzepatid birashobora gusobanura imbaraga zabyo mukugabanya ibiro, bigatanga igisubizo gikomeye kubarwanya umubyibuho ukabije.
Semaglutid na Tirzepatid byombi bigana incretin, ariko bikora muburyo butandukanye bitewe nuburyo bwabo bwo gukora.
Urwego |
Semaglutid |
Tirzepatid |
Igikorwa cyo Kwakira |
GLP-1 reseptor agonist |
Ibikorwa bibiri: GLP-1 na GIP reseptor agonist |
Ingaruka Yibanze |
Igenga ubushake bwo kurya, isukari mu maraso, no gusiba gastric |
Kongera imisemburo ya insuline, kunoza guhaga, no kugenzura isukari mu maraso neza |
Gutakaza ibiro |
Nibyiza mugucunga ibiro binyuze mukugenzura ubushake bwo kurya no kugenzura isukari yamaraso |
Kugabanuka cyane kuburemere bitewe nibikorwa bibiri byakira byongera ubushake bwo kurya no gusubiza insuline |
Semaglutid ikora gusa kuri reseptor ya GLP-1, yigana imisemburo isanzwe ya GLP-1 mu mubiri, igira uruhare runini mu kugenzura ubushake bwo kurya, gusohora insuline, no kurwanya isukari mu maraso. Muguhuza iyi reseptor, Semaglutid ifasha kugenzura umusaruro wa glucose uva mwumwijima, gutinda kwa gastrica, no kugabanya ubushake bwo kurya, bigatuma ukora neza diyabete yo mu bwoko bwa 2 no guteza imbere kugabanya ibiro.
Ibinyuranye na byo, Tirzepatid ikora binyuze muburyo bwuzuye mugukoresha reseptor zombi za GLP-1 na GIP (glucose-iterwa na insulinotropique peptide). Mugihe GLP-1 igira uruhare mukugenzura ubushake bwo kurya no kugenzura isukari mu maraso, GIP nayo igira uruhare mukurekura insuline no kunoza ingufu. Iki gikorwa cyibiri gifasha Tirzepatid kugabanya isukari yamaraso no kongera ibiro neza kurusha Semaglutid. Ku bantu bafite umubyibuho ukabije na diyabete yo mu bwoko bwa 2, Tirzepatid itanga uburyo bukomeye bwo kuvura, cyane cyane kubashaka kugabanya ibiro cyane.
Semaglutid na Tirzepatid zombi zikora kugirango abantu bumve ko buzuye igihe kirekire, bigabanya gufata ibiryo kandi bigashyigikira kugabanya ibiro. Ariko, uburyo bwabo bwo kubikora buratandukanye gato. Semaglutid, ikora gusa kuri reseptor ya GLP-1, ifasha kongera ibyiyumvo byuzuye mugutinda gusiba gastrica no guhagarika ibimenyetso byinzara.
Tirzepatid, kubera ibikorwa byayo bibiri byakira, birashobora kugira ingaruka zikomeye kubihaza no kurya. Mugukoresha GLP-1 na GIP yakira, Tirzepatid itanga ibimenyetso bikomeye mubwonko bwo guhashya inzara no kwifuza, biganisha ku kugenzura neza ibiribwa no kurushaho kubahiriza gahunda zo kugabanya ibiro. Ubu buryo bushobora kuvamo kugabanuka kuramba kandi kugaragara.
Imiti |
Amabwiriza yo kurya |
Ingaruka zo Guhaza |
Semaglutid |
Gutinda gusiba gastric, kugabanya ubushake bwo kurya no kwerekana inzara |
Ingaruka ziciriritse ku guhaga |
Tirzepatid |
Ibikorwa bibiri byakira bitanga imbaraga zo kurwanya ubushake bwo kurya no guhashya inzara |
Ingaruka zikomeye ku guhaga, biganisha ku kubahiriza igihe kirekire gahunda yo kugabanya ibiro |
Uburyo bubiri bwa Tirzepatid butanga uburyo bwo guha abarwayi kwibanda ku kugabanuka gukomeye kandi birambye, kuko byongera mu buryo butaziguye ibyifuzo byo kurya, bikunze kuba ikibazo gikomeye mu micungire y’umubyibuho ukabije.
Igeragezwa rya Clinical ugereranije na Semaglutid na Tirzepatid ryerekanye ubushobozi bwo kugabanya ibiro bya Tirzepatid. Kurugero, ubushakashatsi bwakozwe na Tirzepatid bwerekanye ko gutakaza ibiro 15% kugeza 21%, mugihe Semaglutid yatumye ibiro 17% bigabanuka. Tirzepatid yanagaragaje ibisubizo byiza mu kugabanya umuzenguruko, abitabiriye batakaza impuzandengo ya cm 18.4 ugereranije na cm 13 za Semaglutid.
Mubikorwa byubuvuzi, Tirzepatid akenshi itera kugabanuka cyane ugereranije na Semaglutid. Ibi bituma Tirzepatid ihitamo kubantu bashishikajwe cyane no kugabanya ibiro. Nyamara, ibisubizo bya buri muntu biratandukanye, kandi ibintu nkubuzima, imirire, nigipimo cya metabolike bigira uruhare runini muguhitamo intsinzi yubuvuzi.
Semaglutid na Tirzepatid byombi bisangiye ingaruka ziterwa na gastrointestinal bitewe nuburyo bwabo bwo gutinda gusiba gastric. Muri byo harimo isesemi, kuruka, impiswi, no kubura inda. Mugihe imiti yombi ishobora gutera ibyo bibazo, Tirzepatid irashobora kugira ingaruka nke nkeya zingaruka zikomeye ugereranije na Semaglutid. Nyamara, ibipimo byinshi bya Tirzepatid bikunda gutera ingaruka zigaragara za gastrointestinal, zishobora kubuza abarwayi bamwe.
Kugabanya ingaruka mbi, abatanga ubuvuzi akenshi batangira abarwayi kumupanga muto wa Semaglutid na Tirzepatid, buhoro buhoro bongera igipimo kugirango umubiri uhinduke. Ubu buryo bwa titre bufasha kugabanya uburibwe bwa gastrointestinal. Ni ngombwa kandi gukurikiza gahunda yatanzwe kugirango wirinde ingaruka zitihanganirwa.
Semaglutid itangwa nkinshinge zidasanzwe munsi yicyumweru. Kubantu batangirira kuri Semaglutid kugirango bagabanye ibiro, ibisanzwe byo gutangira ni 0,25 mg buri cyumweru. Igipimo cyiyongera buhoro buhoro mu byumweru byinshi kugirango bigabanye ingaruka mbi, bigera ku gipimo ntarengwa cya mg 2,4 buri cyumweru kugirango ugabanye ibiro.
Semaglutid iraboneka munsi yizina ryinshi bitewe nikoreshwa. Ozempic yandikiwe gucunga diyabete yo mu bwoko bwa 2, Wegovy ni iyo kugabanya ibiro, kandi Rybelsus ni uburyo bwo mu kanwa bukoreshwa mu gucunga diyabete yo mu bwoko bwa 2. Buri fomu isaba kwifata neza no gutondekanya buhoro buhoro kugirango urebe neza kandi igabanye ingaruka zo munda nka isesemi no kuruka.
Tirzepatid nayo itangwa hakoreshejwe inshinge zidasanzwe munsi yicyumweru. Igipimo cyo gutangira kuri Tirzepatid mubusanzwe ni mg 2,5 buri cyumweru, ariko ibi birashobora guhinduka ukurikije intego yo kwihanganira umuntu no kuvura. Igipimo gishobora kwiyongera buhoro buhoro kugeza kuri mg 15 ntarengwa buri cyumweru, bitewe nuburyo umurwayi yakiriye imiti.
Tirzepatid igurishwa ku mazina atandukanye, nka Mounjaro yo gucunga diyabete na Zepbound yo kugabanya ibiro. Kimwe na Semaglutid, Tirzepatid isaba titre yitonze kugirango igabanye ingaruka mbi zo munda, harimo isesemi, kuruka, no gucibwamo. Ni ngombwa ko abarwayi bakorana cyane nabashinzwe ubuzima kugirango bahindure dosiye uko bikwiye.
Mugihe Semaglutid na Tirzepatid byombi bitangwa hakoreshejwe inshinge zicyumweru, Tirzepatid itangirana numuti mwinshi (mg 2,5 mg) ugereranije na Semaglutid (0,25 mg). Imiti yombi yitirirwa buhoro buhoro, ariko urugero rwa Tirzepatid rugera kuri mg 15 mucyumweru, rutanga intera nini yo guhindura imiti ishingiye kubyo abarwayi bakeneye. Ku rundi ruhande, Semaglutid, ifite urugero ntarengwa rusabwa rwa mg 2,4 mu cyumweru kugirango ugabanye ibiro.
Itandukaniro muri dosiye hamwe nibirango byerekana uburyo bwihariye busabwa mugihe ucunga umubyibuho ukabije cyangwa diyabete yo mu bwoko bwa 2 hamwe niyi miti. Nibyingenzi kubarwayi gukurikiza gahunda yo kunywa no gukorana neza nabashinzwe ubuzima kugirango babone ibisubizo byiza.
Mugihe cyo gufata umwanzuro hagati ya Semaglutid na Tirzepatid, hagomba gusuzumwa ibintu byinshi kugirango ubuvuzi bwiza bwumurwayi. Ibintu by'ingenzi tugomba gusuzuma birimo:
Ikintu |
Semaglutid |
Tirzepatid |
Intego zo Gutakaza Ibiro |
Birakwiye kugabanya ibiro bitagereranywa |
Ibyiza kubashaka kugabanya ibiro |
Gucunga Diyabete |
Byibanze bifasha gucunga isukari yamaraso, cyane cyane kubafite ibyago byumutima |
Tanga uburyo bunoze bwo kugenzura isukari mu maraso, cyane cyane ku barwayi bafite umubyibuho ukabije na diyabete |
Ingaruka Zuruhande |
Ibibazo byinshi bya gastrointestinal (isesemi, kuruka) |
Mubisanzwe ingaruka nkeya zikomeye, ariko dosiye nyinshi zirashobora gutuma umuntu agira gastrointestinal ikomeye |
Ubwishingizi |
Ubwishingizi bwagutse, cyane cyane kuvura diyabete |
Igipfukisho gishobora kuba gito, cyane cyane kuvura ibiro |
Buri buzima bwumurwayi akeneye buratandukanye, guhitamo rero hagati ya Semaglutid na Tirzepatid bigomba gushingira kumigambi yubuzima bwa buri muntu. Kurugero, niba kugabanya ibiro arintego yibanze, Tirzepatid irashobora kuba amahitamo meza kubera ingaruka zayo zigaragara. Nyamara, kubarwayi bafite ibyago byumutima nimiyoboro y'amaraso, Semaglutid irashobora kuba amahitamo meza kubera inyungu zagaragaye mukugabanya indwara z'umutima hamwe na risque.
Amateka yubuvuzi nayo ni ikintu cyingenzi. Abarwayi bafite ibibazo bya gastrointestinal cyangwa imiterere yihariye ya comorbid barashobora kubona imiti imwe ikwiranye numubiri wabo kuruta iyindi. Kurugero, Semaglutid irashobora gutera gastrointestinal nyinshi, mugihe Tirzepatid ishobora kwihanganira abarwayi bamwe.
Niba ingaruka mbi zitihanganirwa cyangwa intego zo kuvura zirahinduka, guhinduranya hagati ya Semaglutid na Tirzepatid birashoboka, ariko bigomba gukorwa bigenzurwa nubuvuzi. Guhinduranya hagati yiyi miti bisaba guhindura ibipimo kugirango umutekano wihangane, kuko imiti ifite uburyo butandukanye bwibikorwa.
Semaglutid na Tirzepatid zombi zifite akamaro kanini mu kugabanya ibiro no kurwanya diyabete yo mu bwoko bwa 2. Semaglutid ikora kuri reseptor ya GLP-1, mugihe ibikorwa bya reseptor ya Tirzepatid itanga umusaruro ushimishije, cyane cyane kugabanya ibiro. Imiti yombi izana ingaruka zishobora gusaba gucunga neza.
Guhitamo hagati ya Semaglutid na Tirzepatid bigomba gukorwa hifashishijwe ubuyobozi bw’ubuzima, urebye intego z’ubuzima bwa buri muntu n’amateka y’ubuvuzi.
Cocer Peptides ™ itanga ibisubizo byihariye kugirango ishyigikire ibiro, itanga agaciro binyuze muri peptide yateye imbere.
Igisubizo: Semaglutid ikora kuri reseptor ya GLP-1, mugihe Tirzepatid ihuza ibikorwa bya GLP-1 na reseptor ya GIP kugirango ikore neza.
Igisubizo: Imiti yombi ifasha kugabanya ibiro mugukumira ubushake bwo kurya no kwisukari mu maraso, hamwe na Tirzepatid ikunze kwerekana ibisubizo byiza.
Igisubizo: Igikorwa cya kabiri cya reseptor ya Tirzepatid gitanga ingaruka zikomeye mugutakaza ibiro ugereranije nigikorwa kimwe cya Semaglutid GLP-1.
Igisubizo: Imiti yombi irashobora gutera ibibazo bya gastrointestinal, ariko Tirzepatid mubisanzwe itera ingaruka nkeya kurenza Semaglutid.
Igisubizo: Ibiyobyabwenge byombi bitangwa hakoreshejwe inshinge zicyumweru, hamwe noguhindura dosiye ukurikije kwihanganira umuntu.
Igisubizo: Tirzepatid itanga inyungu zo kugabanya ibiro hamwe no kugenzura isukari mu maraso bitewe nibikorwa byayo byombi.
